Kidney & Urology Foundation of America
Kidney & Urology Foundation of America
SAVE THE DATE:
Support Walk the Walk
New York Walk the Walk

October 31, 2010 - Central Park
REGISTER ONLINE NOW!
join us on Facebook
Join KUFA today
and become an essential part of the fight to save and improve lives. There are no fees for patients, family and friends to get connected!

 

Patient Resources


Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials


A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Andalusia : Research Site

COPD Research Study

Anniston : TR31 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : TR7

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : TR20

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : Research Site

COPD Research Study

Birmingham : Achieve Clinical Research, LLC an Accel Research Site

Long term safety study of QVA149 in COPD patients with moderate to sever airflow limitation.

Andalusia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Birmingham : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Birmingham : UAB Lung Health Center

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Birmingham : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Birmingham : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Birmingham : Forest Investigative Site 3836

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham : Forest Investigative Site 3056

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Birmingham : University of Alabama Birmingham Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Florence : Forest Investigative Site 3438

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Foley : Forest Investigative Site 3729

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntsville : Forest Investigative Site 3911

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jasper : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Jasper : Forest Investigative Site 2423

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mobile : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mobile : Forest Investigative Site 4030

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arizona

Flagstaff : TR14 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Flagstaff : Research Site

COPD Research Study

Phoenix : Arizona Research Center

A Long-Term, Randomized, Double-Blind Study of the Safety, Tolerability and Efficacy of Aclidinium Bromide At Two Dosage Levels When Administered to Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease

Phoenix : TR76 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : TR47 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : TR79 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Phoenix : Research Site

COPD Research Study

Phoenix : Elite Clinical Studies, LLC

Is COPD Leaving You Breathless? Right now we're enrolling adults with COPD ages 40 or older in a research study of an investigational medication for COPD.

Tucson : TR46

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Chandler : Forest Investigative Site 3731

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chandler : Forest Investigative Site 4015

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chandler : Forest Investigative Site 3164

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Flagstaff :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Flagstaff : Forest Investigative Site 3904

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Glendale : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mesa : Forest Investigative Site 4032

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Phoenix : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Phoenix : Forest Investigative Site 3850

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 4003

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Phoenix : Forest Investigative Site 3135

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 4024

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 4031

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 3968

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tempe : Forest Investigative Site 3673

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3726

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 4016

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 3917

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tucson : Forest Investigative Site 4046

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arkansas

Hot Springs : Forest Investigative Site 4009

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Little Rock : Forest Investigative Site 3810

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Little Rock : Forest Investigative Site 3837

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

California

Bakersfield : Research Site

COPD Research Study

Bell Gardens : TR45

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Fullerton : TR16

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Huntington : Research Site

COPD Research Study

Huntington Park : Research Site

COPD Research Study

Lakewood : Research Site

COPD Research Study

Lomita : Research Site

COPD Research Study

Los Angeles : TR59 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Los Angeles : Research Site

COPD Research Study

Newport Beach : Research Site

COPD Research Study

Palm Springs : TR57 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Paramount : Center for Clinical Trials, LLC

Attention Smokers and Ex-Smokers Clinical Research Study Participants Needed

Rancho Mirage : Research Site

COPD Research Study

Sacramento : Northern California Research

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD

San Diego : TR4 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

San Diego : Encompass Clinical Research

Do you have breathing problems?

San Jose : TR77 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Spring Valley : Encompass Clinical Research

Do you have breathing problems?

Spring Valley : Encompass Clinical Research

Has a long history of smoking left you breathless?

Thousand Oaks : Research Site

COPD Research Study

Bakersfield : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Cerritos : Forest Investigative Site 3750

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Costa Mesa : Forest Investigative Site 3898

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

El Cajon :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Encinitas : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Encinitas : Forest Investigative Site 2402

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gold River : Forest Investigative Site 3410

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntington Beach : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Huntington beach : Forest Investigative Site 4022

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntington Park : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Laguna Hills : Forest Investigative Site 3866

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3415

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Los Angeles : University of California at Los Angeles Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Los Angeles : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Los Angeles : UCLA

Patients are needed to participate in a clinical research study evaluating Nebulized arformoterol and Salmeterol for the treatment of Chronic Obstructive Pulmonary Disease, COPD, Emphysema or Chronic Bronchitis

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Forest Investigative Site 3757

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Los Angeles : Forest Investigative Site 3471

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mission Hills :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Newport Beach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Newport Beach : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Newport Beach : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Northridge : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Northridge : Forest Investigative Site 3720

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Northridge : Forest Investigative Site 3930

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Palm Springs : Forest Investigative Site 3727

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Paramount : Forest Investigative Site 3087

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pismo Beach : Forest Investigative Site 3686

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Port Hueneme : Forest Investigative Site 3861

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Poway : Forest Investigative Site 3751

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rancho Mirage : California Stem Cell Treatment Center

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

Rancho Mirage : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Rialto : Forest Investigative Site 3952

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Riverside : Kaiser Permanente Riverside Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Riverside : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Riverside : Forest Investigative Site 2399

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rolling Hills Estates : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Roseville : Forest Investigative Site 3973

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sacramento : Forest Investigative Site 3806

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sacramento : Forest Investigative Site 3083

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

San Diego : Institute of Healthcare Assessments Inc. Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

San Diego : University of California San Diego

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

San Diego : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

San Diego :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

San Diego :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

San Diego : Forest Investigative Site 2345

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Diego : Forest Investigative Site 3707

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Francisco : Forest Investigative Site 3970

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Jose : Forest Investigative Site 3971

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Ana : Forest Investigative Site 4035

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Monica : Forest Investigative Site 3890

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Santa Monica : Forest Investigative Site 3964

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Stockton : Forest Investigative Site 3749

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Thousand Oaks : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Torrance : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Torrance : Harbor UCLA Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Torrance : 1237.16.01601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Upland : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Vista : Forest Investigative Site 3427

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Walnut Creek : Forest Investigative Site 2378

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Whittier : Forest Investigative Site 3719

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Whittier : Forest Investigative Site 3943

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wildomar : Forest Investigative Site 3977

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado

Boulder : Alpine Clinical Research Center

Study comparing a fixed dose, orally inhaled triple therapy to reduce the rate of moderate and severe exacerbations compared with a fixed dose dual combinations of FF/VI and UMEC/VI in subjects with COPD.

Colorado Springs : TR80 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Aurora : University of Colorado Hospital

Patients are needed to participate in a clinical research study evaluating Plerixafor mobilization of autologous CD117 stem cells for the treatment of COPD, Cystic Fibrosis or Pulmonary Fibrosis

Boulder : Forest Investigative Site 3150

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado Springs : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Colorado Springs : Forest Investigative Site 2707

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Colorado Springs : Forest Investigative Site 3944

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Denver : National Jewish Health

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Golden : Forest Investigative Site 2993

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Northglenn : Forest Investigative Site 3716

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Connecticut

Waterbury : TR81 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Waterbury : Chase Medical Research, LLC

Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 4 Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Moderate to Very Severe COPD (ASCENT COPD). Protocol LAS-MD-45 'ASCENT'

Bristol : Forest Investigative Site 3959

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Danbury : 1012.65.00001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Combivent Respimat via ventilator adapter for the treatment of Pulmonary Disease, Chronic Obstructive

Stamford : Forest Investigative Site 3151

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waterbury : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Waterbury : Forest Investigative Site 2461

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waterbury : Forest Investigative Site 3519

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delaware

Newark : Christiana Care Health System

A clinical trial to evaluate treatments for patients with Dyspnea

Wilmington : Forest Investigative Site 3746

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Florida

Brandon : Research Site

COPD Research Study

Clearwater : Research Site

COPD Research Study

Clearwater : Clinical Research of West Florida, Inc. Updated

Do you have a chronic cough, shortness of breath, or difficulty breathing? Have you been diagnosed with chronic bronchitis, emphysema, or Chronic Obstructive Pulmonary Disease (COPD)?

Clearwater : Clinical Research of West Florida, Inc. Updated

Do you have COPD, Emphysema or Chronic Bronchitis?

Debary : Research Site New

COPD Research Study

DeLand : TR18 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Deland : Research Site

COPD Research Study

Doral : TR72

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Edgewater : Research Site

COPD Research Study

Fort Myers : TR50 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Gainesville : TR34

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Hialeah : Research Site

COPD Research Study

Homestead : Research Site

COPD Research Study

Kissimmee : TR29 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Kissimmee : Research Site

COPD Research Study

Miami : Research Site

COPD Research Study

Miami : Research Site

COPD Research Study

Miami : Research Site

COPD Research Study

Miami : Research Site

COPD Research Study

Miami : Research Site

COPD Research Study

Miami Springs : Research Site

COPD Research Study

New Port Richey : TR35 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Orlando : Research Site

COPD Research Study

Orlando : Research Site

COPD Research Study

Orlando : Research Site

COPD Research Study

Ormond Beach : TR61 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Palm Harbor : TR42 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Panama City : Research Site

COPD Research Study

Panama City : Emerald Coast Research Associates

Research Study for Chronic Obstructive Pulmonary Disease

Panama City : Emerald Coast Research Associates

Research Study for Chronic Obstructive Pulmonary Disease (COPD)

Pensacola : Pensacola Research Consultants Inc.

A Phase 3 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).

Pensacola : Pensacola Research Consultants Inc.

A Phase 4 clinical study for patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who experience COPD exacerbations.

Pensacola : Research Site

COPD Research Study

Port Charlotte : Research Site

COPD Research Study

Port Orange : Research Site

COPD Research Study

Saint Petersburg : Research Site

COPD Research Study

Sarasota : TR41 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Sebring : Research Site

COPD Research Study

St. Petersburg : SCORE Physician Alliance

A COPD Study is being conducted to reveal the impact of SYMBICORT in reducing exacerbations in COPD.

Tamarac : TR21 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Tamarac : Central Medical Group, P.A Research

Have you been diagnosed with COPD ?

Tamarac : Central Medical Group, P.A Research

Have you been diagnosed with COPD? We are seeking participants who are currently taking Advair or Symbicort on a daily basis to evaluate an investigational medication for COPD

Tampa : Clinical Research of West Florida, Inc. Updated

Are you a current or former smoker?

Tampa : TR53

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Tampa : Research Site

COPD Research Study

Vero Beach : Research Site New

COPD Research Study

Wellington : Research Site New

COPD Research Study

Winter Park : TR83 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Boynton Beach : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Brandon :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Brandon : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Brandon : Forest Investigative Site 3733

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Brandon : Forest Investigative Site 2722

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Brandon : Forest Investigative Site 3487

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clearwater : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Clearwater : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Clearwater : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Clearwater : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Clearwater : Forest Investigative Site 3811

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clearwater : Forest Investigative Site 2721

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Coral Gables :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Coral Gables : Forest Investigative Site 3834

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Davie : Melvin Propis M.D.

A clinical trial to evaluate treatments using Adipose Derived Stem Cell (ADSC) Therapy for patients with Chronic Obstructive Pulmonary Disease (COPD)

Daytona Beach : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Daytona Beach : Forest Investigative Site 3945

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Debary : Forest Investigative Site 3500

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

DeLand : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Deland : Forest Investigative Site 3990

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delray Beach : Forest Investigative Site 3859

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Edgewater : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fort Lauderdale : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Hialeah : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 4029

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3897

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3992

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3068

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3863

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hialeah : Forest Investigative Site 3947

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hollywood : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hollywood :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Hollywood : Forest Investigative Site 2960

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Homestead : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Jacksonville : Mayo Clinic Jacksonville

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Jacksonville : University of Florida, Jacksonville

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension or Chronic Obstructive Pulmonary Disease

Jacksonville : Forest Investigative Site 3818

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Jupiter : Forest Investigative Site 3804

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Pulmonary Disease Specialist/PDS Research

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Kissimmee : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Kissimmee : Forest Investigative Site 3000

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 3833

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 3783

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kissimmee : Forest Investigative Site 475

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Leesburg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Maitland : Forest Investigative Site 3664

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Melbourne : Forest Investigative Site 3955

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Armando Pineda Velez

A clinical trial to evaluate treatments using Adipose Derived Stem Cells for patients with Chronic Obstructive Pulmonary Disease

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Miami : Well Pharma Medical Research

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Miami : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Miami : Ageless Institute

Patients are needed to participate in a clinical research study evaluating Adipose-Derived Stem Cell (ADSC) Therapy for the treatment of Chronic Obstructive Pulmonary Disease

Miami : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Miami : Forest Investigative Site 3424

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3928

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3938

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3724

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3942

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3921

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3950

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3978

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3844

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3948

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3790

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3918

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 3795

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami : Forest Investigative Site 4023

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami Beach : Forest Investigative Site 3872

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Miami Springs : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Miramar : Forest Investigative Site 3758

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Naples : Forest Investigative Site 3362

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Port Richey :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

New Port Richey : Forest Investigative Site 3761

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocala : Forest Investigative Site 3794

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocala : Forest Investigative Site 4033

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Orlando : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Orlando : Florida Hospital

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Orlando : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Orlando :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Orlando : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Orlando : Forest Investigative Site 3111

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ormond Beach : Forest Investigative Site 2714

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oviedo : Forest Investigative Site 3693

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Panama City : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Panama City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Pembroke Pines : Forest Investigative Site 3925

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pensacola : Forest Investigative Site 2536

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pinellas Park :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Port Charlotte : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Port Orange : Forest Investigative Site 2954

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sarasota : Sarasota Memorial Hospital

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Sarasota : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sarasota : Forest Investigative Site 3360

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sebring : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Sebring : Forest Investigative Site 4042

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Seminole : Forest Investigative Site 3858

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Miami : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

St. Petersburg : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

St. Petersburg : Forest Investigative Site 3426

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 4028

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3807

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Petersburg : Forest Investigative Site 3645

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tamarac : Forest Investigative Site 2417

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tampa : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Tampa : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tampa : Forest Investigative Site 2386

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wellington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Florida Premier Research Institute

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Winter Park : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Winter Park : Forest Investigative Site 3988

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winter Park : Forest Investigative Site 2751

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Georgia

Atlanta : NeuroTrials Research

Breathe New Life into COPD Research!

Blue Ridge : River Birch Research Alliance, LLC

COPD (Chronic Obstructive Pulmonary Disease)

Calhoun : Research Site

COPD Research Study

Columbus : Columbus Regional Research Institute

Chronic Obstructive Pulmonary Disease which includes chronic bronchitis and emphysema

Columbus : Columbus Regional Research Institute

Do you have COPD, Emphysema or Chronic Bronchitis?

Columbus : Columbus Regional Research Institute

Do you or a loved one live with COPD, also known as emphysema or chronic bronchitis? If so, you may be interested in a local clinical research opportunity.

Duluth : TR15

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Lawrenceville : TR25

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Savannah : Southeast Regional Research Group (SRRG)

Do you have COPD* (Chronic Obstructive Pulmonary Disease)

Savannah : Southeast Regional Research Group - Savannah

Do you or a loved one live with COPD, also known as emphysema or chronic bronchitis? If so, you may be interested in a local clinical research opportunity.

Woodstock : Research Site

COPD Research Study

Atlanta : Piedmont Hospital

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Atlanta :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Atlanta : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Atlanta : Forest Investigative Site 2542

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Blue Ridge : Forest Investigative Site 2746

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Calhoun : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Gainesville : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Johns Creek : Forest Investigative Site 3869

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lawrenceville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Marietta : Forest Investigative Site 3669

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norcross : Forest Investigative Site 3868

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oakwood : Forest Investigative Site 3747

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rincon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Savannah : Forest Investigative Site 3989

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Snellville : Forest Investigative Site 3832

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Snellville : Forest Investigative Site 3672

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Stockbridge : Forest Investigative Site 4045

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Woodstock : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Woodstock : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Woodstock : Forest Investigative Site 2424

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho

Eagle : Research Site New

COPD Research Study

Coeur d'Alene : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Coeur d'Alene : Forest Investigative Site 2666

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Eagle : Forest Investigative Site 3400

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hayden Lake : Forest Investigative Site 3839

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3812

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3913

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Idaho Falls : Forest Investigative Site 3979

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Meridian : Forest Investigative Site 3755

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Illinois

Aurora : Research Site

COPD Research Study

Normal : TR27 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Skokie : TR40

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Burr Ridge : Forest Investigative Site 3725

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chicago : University of Chicago

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Chicago : University of Chicago Medical Center

A clinical trial to evaluate treatments using Placebo and Nebivolol for patients with High Blood Pressure

Chicago :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Evergreen Park : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Gillespie : Forest Investigative Site 3784

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morton : Forest Investigative Site 3680

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Normal : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Normal : Forest Investigative Site 3651

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

O'Fallon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

O'Fallon : Forest Investigative Site 2967

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Peoria : Forest Investigative Site 3908

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Indiana

Anderson : Community Clinical Research Center

A Randomized, Double-Blind (Test Products and Placebo), Chronic Dosing (24 Weeks), Placebo-Controlled, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD, Compared With Placebo and Spiriva® Handihaler® (Tiotropium Bromide 18 µg, Open-Label) as an Active Control

Valparaiso : Research Site

COPD Research Study

Avon : Forest Investigative Site 3709

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Michigan City :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Michigan City : Forest Investigative Site 3789

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Muncie : Forest Investigative Site 3756

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Muncie : Forest Investigative Site 3656

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Valparaiso : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Valparaiso : Forest Investigative Site 3966

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Iowa

Ames : Forest Investigative Site 3936

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Council Bluffs : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Iowa City : University of Iowa

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Kansas

Kansas City : Forest Investigative Site 3702

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lenexa : Forest Investigative Site 3855

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pratt : Forest Investigative Site 3999

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Topeka : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Topeka : Forest Investigative Site 2634

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Kentucky

Fort Mitchell : Research Site

COPD Research Study

Lexington : Kentucky Medical Research

COPD Moderate to Severe

Lexington : University of Kentucky Chandler Medical Center

Research Participants Needed - The COPD Health Screening Study

Bowling Green : Forest Investigative Site 2372

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Elizabethtown : Forest Investigative Site 3828

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hazard : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Lexington : University of Kentucky

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lexington : Forest Investigative Site 3856

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisville : University of Louisville, Pulmonary Division

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Louisville : Forest Investigative Site 3045

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Madisonville : Forest Investigative Site 3933

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Louisiana

Zachary : TR51 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Covington : Forest Investigative Site 3881

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Eunice : Forest Investigative Site 3793

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lafayette : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Metairie : Forest Investigative Site 3880

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Orleans : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

New Orleans : Forest Investigative Site 3878

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Opelousas : Forest Investigative Site 3355

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shreveport : Forest Investigative Site 3961

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Slidell : Forest Investigative Site 3661

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sunset : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Sunset : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Zachary : Forest Investigative Site 3800

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Maine

Bangor : Forest Investigative Site 3357

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Biddeford : Forest Investigative Site 3886

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Maryland

White Marsh : Research Site

COPD Research Study

Annapolis :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Baltimore : University of Maryland

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Baltimore : Forest Investigative Site 3025

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Columbia : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Columbia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Elkridge : Forest Investigative Site 3689

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Towson : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Towson : Forest Investigative Site 3670

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Towson : Forest Investigative Site 3883

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

White Marsh : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Massachusetts

Fall River : TR33 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Fall River : Research Site

COPD Research Study

North Dartmouth : Research Site

COPD Research Study

Boston : Beth Israel Deaconess Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Boston : Brigham and Women's Hospital

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Burlington : Lahey Clinic

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Fall River : Forest Investigative Site 3124

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Dartmouth : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

North Dartmouth : Forest Investigative Site 2549

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waltham :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Worcester : Reliant Medical Group

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Michigan

Ann Arbor : ClinSite, LLC

Diagnosed with COPD, Chronic Bronchitis or Emphysema?

Bingham Farms : QUEST Research Institute

Chronic Obstructive Pulmonary Disease Study

Buckley : Research Site

COPD Research Study

Kalamazoo : TR78 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Kalamazoo : Research Site

COPD Research Study

Livonia : Research Site

COPD Research Study

Rochester : Research Site

COPD Research Study

Troy : Research Site

COPD Research Study

Ann Arbor : University of Michigan Health System

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bingham Farms : Forest Investigative Site 4018

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Buckley : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Buckley : Forest Investigative Site 4013

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chesterfield : Forest Investigative Site 3969

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clinton Township : Forest Investigative Site 3899

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Flint :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Kalamazoo : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Livonia : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Livonia : Forest Investigative Site 2498

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rochester : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Stevensville : Forest Investigative Site 3035

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Traverse City : Forest Investigative Site 3156

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Minnesota

Edina : Research Site

COPD Research Study

Fridley : Research Site

COPD Research Study

Minneapolis : TR2 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : Research Site

COPD Research Study

Minneapolis : Clinical Research Institute, MN

COPD Research Study for Smokers or Ex-Smokers

Plymouth : TR1 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Woodbury : Research Site

COPD Research Study

Edina : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Edina : Minnesota Lung Center Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Edina : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edina : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fridley : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Fridley : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Minneapolis : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Minneapolis : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Minneapolis : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Minneapolis : Forest Investigative Site 2381

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Minneappolis : Minnesota Lung Center Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Plymouth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Woodbury : Minnesota Lung Center Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Woodbury : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Missouri

St. Charles : Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

St. Charles : Midwest Chest Consultants, PC

A Phase III, 52-week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease.

St. Charles : Midwest Chest Consultants, PC New

GOLDEN-5 - A nebulized study medication for Obstructive Lung Disease

St. Charles : Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

St. Louis : Midwest Clinical Research LLC

Are you a current or former smoker? Do you have a diagnosis of Chronic Obstructive Pulmonary Disease or COPD?

St. Louis : TR23 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

St. Louis : The Clinical Research Center, LLC New

Have you experienced a flare-up in your COPD symptoms over the past year?

Kansas City : Forest Investigative Site 3154

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Saint Charles : Midwest Chest Consultants PC Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Springfield : Forest Investigative Site 3411

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Charles : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

St. Charles : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

St. Charles : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St. Charles : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

St. Charles : Forest Investigative Site 2413

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

St. Louis : Washington University in St. Louis

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

St. Louis :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

St. Louis : Forest Investigative Site 2956

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3696

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3799

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louis : Forest Investigative Site 3028

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

St. Louise : The Clinical Research Center Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Montana

Billings : TR11 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Missoula : Research Site

COPD Research Study

Missoula : Montana Medical Research, Inc.

Do You Have COPD, Emphysema or Chronic Bronchitis?

Missoula : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Missoula : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Missoula : Forest Investigative Site 2957

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Nebraska

Fremont : Research Site

COPD Research Study

Bellevue : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Bellevue : Forest Investigative Site 2972

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Bellevue : Forest Investigative Site 3808

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fremont : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fremont : Forest Investigative Site 3873

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Grand Island : Forest Investigative Site 3910

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Lincoln : Forest Investigative Site 3896

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3167

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lincoln : Forest Investigative Site 3358

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Omaha : UNMC College of Medicine

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

Omaha :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Omaha : University of Nebraska Medical Center

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 3653

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 3451

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 2982

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : Forest Investigative Site 4002

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Omaha : University of Nebraska Medical Center

Patients are needed to participate in a clinical research study to evaluate COPD

Papillion : Forest Investigative Site 3877

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Papillion : Forest Investigative Site 3997

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Nevada

Las Vegas : TR65

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Las Vegas : Research Site

COPD Research Study

Las Vegas : Forest Investigative Site 3779

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3874

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 3906

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Las Vegas : Forest Investigative Site 2973

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Jersey

Jersey City : CarePoint Health Research Institute

Having difficulty breathing? Have you been diagnosed with COPD?

Linden : Biomedical Research Alliance of New York

Chronic Obstructive Pulmonary Disease (COPD) and a history of or at risk for cardiovascular disease - Adults

East Brunswick : Forest Investigative Site 3835

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Elizabeth : Forest Investigative Site 3932

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Haddon Heights : Forest Investigative Site 3674

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ocean : Forest Investigative Site 2944

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Summit : Forest Investigative Site 2418

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toms River : Forest Investigative Site 3743

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Warren : Forest Investigative Site 3902

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Mexico

Albuquerque : Forest Investigative Site 2393

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New York

Bronxville : TR36 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Bronxville : Research Site

COPD Research Study

Brooklyn : Research Site

COPD Research Study

Buffalo : TR71 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Elmira : Health Sciences Research Center

Attention Smokers and Ex-smokers. Do you have trouble breathing or a persistent cough?

Endwell : Regional Clinical Research, Inc.

A national study for people with shortness of breath and other respiratory problems.

Endwell : Regional Clinical Research, Inc.

Do you have any of these problems? Shortness of Breath? Cough? Chronic Bronchitis? Emphysema? Wheezing? Phlegm? Chronic Obstructive Pulmonary Disease?

New Hyde Park : Parker Jewish Institute

People with Chronic Obstructive Pulmonary Disease are asked to participate in a research study being conducted at Parker Jewish Institute for Health Care and Rehabilitation

Rochester : TR62 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Rochester : AAIR Research Center

Symbicort or Formoterol COPD Study

Syracuse : Research Site

COPD Research Study

Bayside :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Bronx : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Bronx : Lincoln Medical and Mental Health Center

A clinical trial to evaluate treatments for patients with Dyspnea

Bronx : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Brooklyn : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Brooklyn : Forest Investigative Site 2532

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Hills : Forest Investigative Site 3843

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Great Neck : Forest Investigative Site 2720

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Hyde Park : Forest Investigative Site 3851

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New Windsor : Forest Investigative Site 3110

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

New York : Columbia University Medical center / New York Presbyterian Hospital

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease (COPD)

New York : Mount Sinai School of Medicine

A clinical trial to evaluate treatments for patients with Dyspnea

New York : Forest Investigative Site 3782

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Syracuse : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Syracuse : Forest Investigative Site 3118

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Westfield : Forest Investigative Site 3671

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Carolina

Boone : TR66

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Burlington : Research Site New

COPD Research Study

Calabash : Research Site

COPD Research Study

Charlotte : Research Site

COPD Research Study

Hendersonville : TR24 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Huntersville : TR17 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Raleigh : PMG Research of Raleigh

Do you have Swimmer's Ear?

Salisbury : TR43 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Shelby : Research Site

COPD Research Study

Wilmington : PMG Research of Wilmington

Chronic Obstructive Pulmonary Disease (COPD) – History of Flare-Ups (Exacerbations)

Wilmington : Research Site New

COPD Research Study

Wilmington : PMG Research of Wilmington

COPD Study – Past or Current Cigarette Smokers

Wilmington : PMG Research of Wilmington

If you have Chronic Obstructive Pulmonary Disease (COPD), you need to know about Alpha-1 Antitrypsin Deficiency.

Winston-Salem : TR30 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Asheville : Forest Investigative Site 3658

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Calabash : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Chapel Hill : UNC-Chapel Hill

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Charlotte : Carolinas Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Charlotte : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Charlotte : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Charlotte :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Charlotte : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Charlotte : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Charlotte : Forest Investigative Site 3091

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3785

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3909

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3768

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlotte : Forest Investigative Site 3965

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Durham : Duke University Medical Center

Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability

Gastonia : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Greensboro : Forest Investigative Site 3983

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : Forest Investigative Site 3923

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

High Point : Forest Investigative Site 3903

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Huntersville : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Lenoir : Forest Investigative Site 3736

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mooresville : Forest Investigative Site 3688

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morehead City :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Salisbury : Forest Investigative Site 3889

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sanford : Forest Investigative Site 3694

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Shelby : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Shelby : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Shelby : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Shelby : Forest Investigative Site 3142

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Statesville : Forest Investigative Site 2953

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wilmington : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Wilmington : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Wilmington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Wilmington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Wilmington : Forest Investigative Site 3109

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Winston-Salem : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Winston-Salem : Wake Forest University Baptist Medical Center

Patients are needed to participate in a clinical research study evaluating NIOX MINO® for the treatment of Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3791

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 4019

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3796

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winston-Salem : Forest Investigative Site 3786

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

North Dakota

Fargo : Forest Investigative Site 3687

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ohio

Canton : Research Site

COPD Research Study

Cincinnati : Research Site

COPD Research Study

Columbus : TR68 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Columbus : TR54 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Columbus : Research Site

COPD Research Study

Dayton : TR85 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Kettering : TR37

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Marion : Research Site

COPD Research Study

Toledo : Research Site

COPD Research Study

Willoughby : TR32

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Canton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Canton : Forest Investigative Site 2704

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Cincinnati : Cincinnati Children's Hospital in partnership with University Hospital of Cincinnati

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

Cincinnati : University of Cincinnati

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Cincinnati : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Cincinnati : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Cincinnati : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Cincinnati : Forest Investigative Site 2343

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : Forest Investigative Site 4007

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cincinnati : Forest Investigative Site 3780

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Cleveland : Metrohealth Medical Center

A clinical trial to evaluate treatments for patients with Dyspnea

Cleveland : The Cleveland Clinic

Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing

Columbus : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Columbus : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Columbus : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Columbus : Forest Investigative Site 2980

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dayton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Dayton : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Dayton : Forest Investigative Site 3655

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dayton : Forest Investigative Site 3648

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Delaware : Forest Investigative Site 3708

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dublin : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dublin : Forest Investigative Site 3665

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Marion : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Maumee : Forest Investigative Site 3710

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norwood : Forest Investigative Site 3972

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sylvania : Forest Investigative Site 2425

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toledo : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Toledo : Forest Investigative Site 3713

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toledo : Forest Investigative Site 3646

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma

Oklahoma City : TR55 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Oklahoma City : Research Site

COPD Research Study

Oklahoma City : Research Site

COPD Research Study

Norman : Forest Investigative Site 3691

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Oklahoma City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Oklahoma City : Forest Investigative Site 3699

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3695

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oklahoma City : Forest Investigative Site 3654

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tulsa : Forest Investigative Site 4025

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tulsa : Forest Investigative Site 4027

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Oregon

Eugene : TR52 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Medford : Sunstone Medical Research, LLC

Seeking past or current smokers with severe COPD (Chronic Obstructive Pulmonary Disease) also known as emphysema or chronic bronchitis, to participant in a Clinical Research Study.

Clackamas : Kaiser Permanente Northwest Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Medford : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Medford : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Medford :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Medford : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Medford : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Medford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Portland : Forest Investigative Site 3766

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pennsylvania

Bethlehem Township : TR38

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Lansdale : TR75

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Philadelphia : Research Site New

COPD Research Study

Pittsburgh : TR71 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : TR74 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Pittsburgh : Research Site New

COPD Research Study

Uniontown : TR67 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Uniontown : Research Site

COPD Research Study

Abington : Forest Investigative Site 3723

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Altoona : Forest Investigative Site 3935

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Beaver : Forest Investigative Site 3650

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Carnegie : Forest Investigative Site 3681

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clairton : Forest Investigative Site 4000

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Downingtown : Forest Investigative Site 3363

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Erie : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Erie : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Erie : Forest Investigative Site 2352

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Harleysville : Forest Investigative Site 3957

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Harleysville : Forest Investigative Site 3692

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hershey : Penn State Milton S. Hershey Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Jefferson Hills : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Langhorne : Forest Investigative Site 3745

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Monroeville : Forest Investigative Site 3685

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Penndel : Forest Investigative Site 3690

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Perryopolis : Forest Investigative Site 3774

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Perryopolis : Forest Investigative Site 3801

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Philadelphia : University of Pennsylvania

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Philadelphia : Pennsylvania Hospital

A clinical trial to evaluate treatments for patients with Dyspnea

Philadelphia : Temple University Hospital

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Philadelphia : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Philadelphia : Temple University Medical Center

Patients are needed to participate in a clinical research study of Budesonide+ ipratropium/albuterol, budesonide/formoterol plus ipratropium/albuterol and Ipratropium/albuterol to evaluate Pulmonary Disease, Chronic Obstructive

Pittsburgh : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Pittsburgh : Forest Investigative Site 2715

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pittsburgh : Forest Investigative Site 3115

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Smithfield : Forest Investigative Site 3704

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tipton : Forest Investigative Site 3016

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Uniontown : Forest Investigative Site 3684

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : Forest Investigative Site 3659

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Uniontown : Forest Investigative Site 3119

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Upper St. Clair : Forest Investigative Site 3885

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Warminster : Forest Investigative Site 3676

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wyomissing : Forest Investigative Site 3941

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rhode Island

East Greenwich : TR63 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Johnston : Clinical Partners, LLC

Chronic Bronchitis or Emphysema-also known as Chronic Obstructive Pulmonary Disease which is most often caused by cigarette smoking.

East Providence : Forest Investigative Site 2678

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Carolina

Anderson : TR22 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Anderson : TR56 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Charleston : Research Site

COPD Research Study

Easley : TR13 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Easley : Research Site New

COPD Research Study

Fort Mill : Research Site

COPD Research Study

Fort Mill : Piedmont Research Partners, LLC

Double-blind, randomized, placebo-controlled, parallel-group, phase IV study to evaluate the effect of Aclidinium Bromide on long-term cardiovascular safety and COPD exacerbations in patients with moderate to severe COPD

Gaffney : TR8 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Greenville : TR69

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Research Site

COPD Research Study

Mt. Pleasant : TR19 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Mt. Pleasant : Research Site New

COPD Research Study

Rock Hill : TR6 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Rock Hill : Research Site

COPD Research Study

Spartanburg : TR9 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : Spartanburg Medical Research

Double-Blind study evaluating the effect of Fluticasone Furoate/Vilanterol Inhalation powder once daily comparted with Vilanterol Inhalation powder once daily on Bone Mineral Density in subjects with COPD.

Spartanburg : Spartanburg Medical Research

Inhaled Nitric Oxide/Inopulse® Ds-C Combination Product

Union : TR3 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Williamston : TR84 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Anderson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Anderson : Forest Investigative Site 3817

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : Lowcountry Lung and Critical Care, PA Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Charleston : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Charleston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Charleston : Forest Investigative Site 2407

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : Forest Investigative Site 3647

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charleston : Forest Investigative Site 3344

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Columbia : Forest Investigative Site 3697

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Easley : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Easley : Easley Clinical Research Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Easley : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Easley : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Easley : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Easley : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Fort Mill : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Fort Mill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Mill : Forest Investigative Site 3456

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Gaffney : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Gaffney : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Gaffney : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Gaffney : Forest Investigative Site 3455

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gaffney : Forest Investigative Site 3742

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Greenville : Greenville Pharmaceutical Research, Inc. Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Upstate Pharmaceutical Research, Inc. Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Chandar Abboy

A clinical research study of Peforomist-Placebo and Perforomist, nebulization, COPD for the treatment of COPD

Greenville : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Greenville : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Greenville : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Greenville :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Greenville : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Greenville : Forest Investigative Site 3700

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : Forest Investigative Site 3865

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Greenville : Forest Investigative Site 3679

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hodges : Forest Investigative Site 3924

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Longs : Forest Investigative Site 3778

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mt. Pleasant : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mt. Pleasant : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Mt. Pleasant : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Orangeburg : Forest Investigative Site 3976

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pelzer : Forest Investigative Site 2670

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Rock Hill : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Rock Hill : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Rock Hill : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Rock Hill :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Rock Hill : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Rock Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Seneca : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Seneca : Hope Clinical Research Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Seneca : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Seneca : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Seneca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Spartanburg :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Spartanburg : Pearl Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : Novartis Investigative Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Spartanburg : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Spartanburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Spartanburg : Forest Investigative Site 2691

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Summerville : Forest Investigative Site 3677

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Union : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Union : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Union : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Union : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Union : Forest Investigative Site 3017

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Williamston : Forest Investigative Site 3846

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

South Dakota

Rapid City : Research Site

COPD Research Study

Rapid City : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Rapid City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Rapid City : Forest Investigative Site 2892

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tennessee

Brentwood : TR60

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Bristol : TR73

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Chattanooga : Research Site New

COPD Research Study

Knoxville : TR5 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

New Tazewell : TR26 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Athens : Forest Investigative Site 3841

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Chattanooga : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Chattanooga : Forest Investigative Site 3857

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fayetteville : Forest Investigative Site 3075

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Johnson City : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Knoxville : University of Tennessee Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Knoxville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Shelbyville : Forest Investigative Site 3864

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Spring Hill : Forest Investigative Site 3919

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Texas

Arlington : Research Site

COPD Research Study

Corsicana : Research Site

COPD Research Study

Dallas : TR58

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Duncanville : Research Site

COPD Research Study

Edinburg : Research Site New

COPD Research Study

El Paso : TR39 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Fortworth : Research Site New

COPD Research Study

Houston : Research Site

COPD Research Study

Houston : Research Site

COPD Research Study

Houston : Research Site

COPD Research Study

Houston : Research Site

COPD Research Study

Houston : Research Site

COPD Research Study

Houston : Research Site

COPD Research Study

Houston : DM Clinical Research

Type 2 Diabetes- Houston,TX

Katy : Research Site

COPD Research Study

Kingwood : TR12 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Lewisville : TR49 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Longview : TR64 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Longview : Research Site

COPD Research Study

McKinney : Research Site

COPD Research Study

San Antonio : Allergy Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Lung Diagnostics, LTD

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Diagnostics Research Group

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Women's Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Women's Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Diagnostics Research Group

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Lung Diagnostics, LTD

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : Allergy Diagnostics

Chronic Obstructive Pulmonary Disease (COPD) Research Study

San Antonio : TR10 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

San Antonio : Sun Research Institute

Do you smoke cigarettes? Do you suffer from COPD? You may qualify to participate in a study.

San Antonio : Allergy Diagnostics

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

San Antonio : Lung Diagnostics, LTD

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

San Antonio : Women's Diagnostics

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

San Antonio : Diagnostics Research Group

Seeking individuals who have COPD in San Antonio, Texas and the surrounding areas.

Tomball : DM Clinical Research

COPD (Chronic Obstructive Pulmonary Disease)

Amarillo : Forest Investigative Site 3777

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arlington :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Arlington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Arlington : Forest Investigative Site 3737

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Austin : Forest Investigative Site 3057

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Austin : Forest Investigative Site 0564

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Carrollton : Forest Investigative Site 3738

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Channelview : Forest Investigative Site 3962

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Corsicana : Forest Investigative Site 3359

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dallas : UT Southwestern Medical Center at Dallas

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Dallas :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Dallas :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Dallas :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Dallas : Forest Investigative Site 3435

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dallas : Forest Investigative Site 3798

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Dickinson : Forest Investigative Site 3854

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Duncanville : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fort Worth : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Fort Worth : 1012.65.00002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating Combivent Respimat via ventilator adapter for the treatment of Pulmonary Disease, Chronic Obstructive

Fort Worth : Forest Investigative Site 2348

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Fort Worth : Forest Investigative Site 3862

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Georgetown :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Georgetown : Forest Investigative Site 3870

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Michael DeBakey VA Medical Center

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Houston : Texas Institute of Chest and Sleep Disorders, PA

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Houston : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Houston : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Houston : Forest Investigative Site 3991

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3929

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3871

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Houston : Forest Investigative Site 3922

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Irving : Forest Investigative Site 3714

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving : Forest Investigative Site 3937

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Irving : Forest Investigative Site 3995

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Katy : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Killeen : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Lubbock : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

McKinney : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

North Richland Hills :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

North Richland Hills : Forest Investigative Site 3882

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

San Antonio : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : Diagnostics Research Group

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

San Antonio : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

San Antonio : Forest Investigative Site 3894

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3792

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3953

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3879

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Sugar Land : Forest Investigative Site 3920

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tomball :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Tyler : Forest Investigative Site 2703

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Waco : Forest Investigative Site 3875

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Webster : Forest Investigative Site 3916

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Utah

Bountiful : Research Site New

COPD Research Study

Midvale : Research Site

COPD Research Study

Salt Lake City : Research Site

COPD Research Study

Salt Lake City : Optimum Clinical Research, Inc.

COPD/Emphysema/Chronic Bronchitis

Midvale : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Ogden : Forest Investigative Site 3748

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Ogden : Forest Investigative Site 3963

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Riverton : Forest Investigative Site 4008

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Salt Lake City : University of Utah

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Salt Lake City : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Salt Lake City : Forest Investigative Site 3712

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Virginia

Arlington : Millennium Clinical Trials, L.L.C.

Do you have Chronic Obstructive Pulmonary Disease also known as COPD?

Newport News : Health Research of Hampton Roads, Inc.

Emphysema/COPD/ Chronic Smoker’s Bronchitis Research

Norfolk : TR82 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Virginia Research Center

Adults With COPD - Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease

Richmond : Pulmonary Associates of Richmond, Inc.

Are you being treated for Chronic Obstructive Pulmonary Disease?

Richmond : TR44 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Research Site

COPD Research Study

Richmond : Research Site

COPD Research Study

Richmond : Research Site

COPD Research Study

Abingdon : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Abingdon : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Abingdon : Forest Investigative Site 3047

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Arlington : Forest Investigative Site 3730

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Charlottesville : University of Virginia

A clinical research study of HXe MRI lung ventilation for the treatment of Asthma, COPD or Healthy

Danville : Forest Investigative Site 3981

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Manassas : Forest Investigative Site 3705

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Midlothian : Forest Investigative Site 3776

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Newport News : Forest Investigative Site 3488

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Norfolk : Forest Investigative Site 3852

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Richmond : Virginia Commonwealth University

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Richmond : Virginia Commonwealth University

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease(COPD)

Richmond : Pulmonary Associates of Richmond

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Richmond : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Richmond : Forest Investigative Site 3775

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Richmond : Forest Investigative Site 2460

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Washington

Renton : Rainier Clinical Research Center, Inc.

COPD - Chronic Obstructive Pulmonary Disease - Study. Do You Have COPD?

Tacoma : Pulmonary Consultants, P.L.L.C.

Are you at least 40 years old and have COPD? Did you have worsening of symptoms that required the use of antibiotics, prednisone or hospitalization in the last year?

Tacoma : TR28 Updated

Clinical trial for Chronic Obstructive Pulmonary Disease (COPD)

Tacoma : Pulmonary Consultants, P.L.L.C.

Do you suffer from Diabetes...With Asthma or COPD?

Bellingham : Forest Investigative Site 2690

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Port Orchard : Forest Investigative Site 3711

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Renton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Seattle : University of Washington

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Spokane : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Spokane : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Spokane Valley : Forest Investigative Site 3127

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Tacoma : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Tacoma : Pulmonary Consultants PLLC Updated

A clinical research study of Glycopyrrolate (SUN-101 ) and tiotropium (Spiriva®) for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Tacoma :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Tacoma : Forest Investigative Site 2687

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

West Virginia

Morgantown : Research Site

COPD Research Study

Charleston : Forest Investigative Site 3840

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lewisburg : Forest Investigative Site 3823

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Morgantown : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Morgantown : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Morgantown : Forest Investigative Site 3682

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wisconsin

Kenosha :

A clinical trial to evaluate treatments using Technosphere Insulin and Usual Care for patients

Middleton : Forest Investigative Site 3660

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Milwaukee : Medical College of Wisconsin

A clinical research study of IBV Valve System and Medical Management for the treatment of Emphysema

Verona : Forest Investigative Site 2983

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Verona : Forest Investigative Site 3951

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Argentina

Bahia Blanca : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Buenos Aires : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Buenos Aires : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Buenos Aires : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ciudad de Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Concepción del Uruguay : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Florida : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

La Plata : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Lanus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lanús : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Lanús : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Mar del Plata : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mar del Plata : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mar del Plata : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mar del Plata : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Mendoza : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mendoza : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Quilmes : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Rosario : Novartis Investigative Site

A clinical research study of Indacaterol and Salmeterol for the treatment of Chronic Obstructive Pulmonary Disease

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Salta : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucuman : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

San Miguel de Tucuman : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Santa Fe : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Australia

Clayton : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Daw Park : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Daw Park : 1237.16.61601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Frankston : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Liverpool : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Murdoch : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Murdoch : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Nedlands : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Nedlands : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Toorak Gardens : 1237.16.61602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Wentworthville : Department of Respiratory & Sleep Medicine, Westmead Hospital Updated

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

Austria

Amstetten : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Feldbach : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Feldbach : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Feldkirch : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Feldkirch : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Graz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Grieskirchen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Innsbruck : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Innsbruck : Christian Kähler

Patients are needed to participate in a clinical research study evaluating Nasal oxygen insufflation with a TNI® 20 oxy device and Nasal insufflation of oxygen for the treatment of COPD or Hypercapnia

Kirchdorf an der Krems : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Leoben : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Linz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Linz : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Salzburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Salzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Salzburg : 1237.16.43602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Thalheim bei Wels : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vienna : Otto-Wagner-Spital

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Wels : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Wien : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Wien : 1237.16.43601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Belgium

Aalst : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brussel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Brussels : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Brussels : CHU Saint Pierre

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bruxelles : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edegem : University Hospital Antwerp

A clinical research study of intrapulmonary percussive ventilation and standard treatment for the treatment of Chronic Obstructive Pulmonary Disease

Edegem : Antwerp University Hospital

Patients are needed to participate in a clinical research study of Functional Respiratory Imaging to evaluate Pulmonary Disease, Chronic Obstructive

Eghezée : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Faulx-les-Tombes : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Genk : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Genk : 1237.16.32603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Gent : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gent : Universiteit Gent

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Gilly : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Gilly : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gosselies : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hasselt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hasselt : 1237.16.32602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Ieper : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Jambes : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Jambes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jambes : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Leuven : UZ Gasthuisberg Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Leuven : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Leuven : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Leuven : 1237.16.32601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Leuven : University Hospital Leuven

Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease

Liège : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Liège : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Luxembourg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Malmedy/Bellevaux-Ligneuville : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Mechelen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Menen : AZ Delta

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Montigny-Le-Tilleul : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Oostende : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Oostende : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Roeselare : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Turnhout : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Verviers : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Wavre : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Zottegem : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Brazil

Belo Horizonte : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Florianopolis : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Goiania : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Porto Alegre : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Porto Alegre : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Ribeirao Preto : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Rio de Janeiro : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Sao Paulo : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

São Paulo : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Bulgaria

Dimitrovgrad : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Dupnitza : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Gabrovo : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Gabrovo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Haskova :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Novi Iskar :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Pazardjik :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Pleven :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Pleven : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Pleven : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Plovdiv : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Plovdiv : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Razgrad :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Ruse :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Ruse : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Ruse : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Sofia : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Sofia : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Sofia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Stara Zagora : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Troyan :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Troyan : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Varna :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Varna : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Varna : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vidin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Vratsa :

A clinical study for patients with Chronic Obstructive Pulmonary Disease

Canada

Burlington : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Burlington : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Calgary : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Calgary : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Calgary : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Calgary : University of Calgary

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Downsview : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Edmonton : Links Clinic

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Edmonton : Grey Nuns Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Edmonton : University of Alberta Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Gatineau : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Grimsby : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Halifax : Forest Investigative Site 3652

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hamilton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hamilton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Kingston : Kingston General Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

KIngston : Respiratory Investigation Unit at Kingston General Hospital

Patients are needed to participate in a clinical research study evaluating GSK573719/GW642444 and GSK573719 for the treatment of COPD

Kitchener : Forest Investigative Site 3830

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

La Malbaie : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Langley : Forest Investigative Site 3448

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Lethbridge : Lethbridge Regional Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

London : Forest Investigative Site 3772

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

London : Forest Investigative Site 3754

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Longueuil : Forest Investigative Site 3763

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Mirabel : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Mirabel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Moncton : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Moncton : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Montreal Chest Institute

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Montreal : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montreal : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Montreal : Forest Investigative Site 3495

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Montreal : 1237.16.11601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

North Vancouver : Lion's Gate Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Ottawa : Ottawa Hospital General

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Pointe-Claire : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Institut universitaire de cardiologie et de pneumologie de Québec

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Quebec : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Quebec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Quebec : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Quebec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Québec : Institut universitaire de cardiologie et de pneumologie de Québec

A clinical study for patients with Pulmonary Disease, Chronic Obstructive

Quebec City : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Sainte-Foy : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Sarnia : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Saskatoon : Royal University Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Saskatoon : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Saskatoon : Forest Investigative Site 3753

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Saskatoon : Royal University Hospita

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Saskatoon : 1237.16.11603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Sherwood Park : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Sherwood Park : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

St Charles Borromee : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromée : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

St-Charles-Borromée : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromée : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

St-Charles-Borromée : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

St-Charles-Borromée : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Ste-Foy : 1237.16.11602 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Sudbury : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Sudbury : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Sudbury : Forest Investigative Site 3829

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Toronto : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Toronto : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Toronto : Forest Investigative Site 2742

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Trois Rivieres : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Trois Rivieres : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Trois Rivières : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Truro : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Vancouver : St-Paul's Hospital

A clinical study for patients with COPD or Chronic Obstructive Pulmonary Disease

Vancouver : St. Paul's Hospital

A clinical trial to evaluate treatments for patients with Chronic Obstructive Pulmonary Disease

Vancouver : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Vancouver : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Vancouver : St. Paul' Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Vancouver : Vancouver General Hospital

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Waterloo : Forest Investigative Site 3887

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Wetaskiwin : Wetaskiwin Lung Laboratory

Patients are needed to participate in a clinical research study of Advair and Flovent to evaluate Chronic Obstructive Pulmonary Disease

Windsor : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Windsor : Forest Investigative Site 2535

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Winnipeg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Winnipeg : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Winnipeg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Fluticasone Furoate and Vilanterol for the treatment of Pulmonary Disease, Chronic Obstructive

Chile

Quillota : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Santiago : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Santiago : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Santiago : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Santiago : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Talca : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

China

Beijing : Novartis Investigative Site

A clinical research study for the treatment of COPD

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Changsha : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chengdu : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chengdu : 244.2514.86008 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Chongqing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Chongqing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Guang Zhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Guang Zhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Guangzhou : 244.2514.86006 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Guangzhou : 244.2514.86007 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Guangzhou : 244.2514.86010 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Guangzhou : The First Affiliated Hospital of Guangzhou Medical College

Patients are needed to participate in a clinical research study evaluating Spiration Valve System and Medical Management for the treatment of Empyhsema

Guangzhou : Guangzhou Institute of Respiratory Diseases

Patients are needed to participate in a clinical research study of caspofungin to evaluate Invasive Pulmonary Aspergillosis or Chronic Obstructive Pulmonary Disease

Haikou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hangzhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hangzhou : 244.2514.86009 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Nanchang : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nanjing : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shanghai : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shanghai : 244.2514.86004 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Shengyang : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Shijiazhuang : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Suzhou : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tianjin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tianjin : 244.2514.86002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study evaluating placebo and ipratropium bromide for the treatment of Pulmonary Disease, Chronic Obstructive

Xi'an : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Colombia

Armenia : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bogota : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Floridablanca : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Medellín : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Croatia

Karlovac : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Rijeka : University Hospital Rijeka

A clinical study for patients with COPD, Smoking or Other Diagnoses, Comorbidities, and Complications

Split : Clinical Hospital Center, Split

A clinical study for patients with COPD, Smoking or Other Diagnoses, Comorbidities, and Complications

Zagreb : Children's Hospital Srebrnjak

A clinical study for patients with COPD, Smoking or Other Diagnoses, Comorbidities, and Complications

Zagreb : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Zagreb : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Czech Republic

Benesov : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Boskovice : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Brno :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Cesky Krumlov : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cvikov : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jindrichuv Hradec : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Jindrichuv Hradec :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Jindrichuv Hradec III : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Karlovy Vary : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Karlovy Vary :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Kralupy nad Vltavou : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Liberec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lovosice : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Melnik : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Melnik :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Ostrava : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Ostrava - Hrabuvka : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pardubice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Prague 4 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 10 : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 10 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 4 : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 5 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 5 - Radotin :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Praha 6 : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Praha 6 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 6 - Repy : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Praha 8 : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Praha 8 :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Rokycany : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Rudna : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Strakonice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Strakonice :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Teplice : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Teplice : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Teplice : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Varnsdorf : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Zatec : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Znojmo : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Denmark

Aalborg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Aalborg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Århus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Arhus C : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Copenhagen NV : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hellerup : Dept. of Pulmonary Medicine Y, UH Gentofte

A clinical research study of Nightly NIV for at least 6 hours for the treatment of Chronic Obstructive Pulmonary Disease, Acute Exacerbation of Chronic Obstructive Airways Disease or Chronic Hypercapnic Respiratory Failure

Hellerup : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hvidovre : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Hvidovre : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Kobenhavn NV : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

København NV : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

København NV : 1237.16.45002 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Kolding : 1237.16.45003 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Næstved : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Næstved : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Odense : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Odense : Department of Respiratory Medicine, Odense University Hospital Updated

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

Odense : 1237.16.45001 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Odense C : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Roskilde : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Roskilde : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Silkeborg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Silkeborg : Research Site

A Phase 3 clinical study for patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Sønderborg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Estonia

Paide : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallin : Institute of Clinical Medicine

Patients are needed to participate in a clinical research study of CHROMED monitoring system to evaluate Chronic Obstructive Pulmonary Disease, Congestive Hearth Failure or Sleep Disordered Breathing

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tallinn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallinn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallinn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tallinn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tallinn : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Tallinn : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Tallinn : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Tartu : GSK Investigational Site

A clinical trial seeking patients for a Chronic Obstructive Pulmonary Disease (COPD) treatment research study

Tartu : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tartu : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Tartu : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Finland

Helsinki : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Helsinki : Biomedicum Helsinki Updated

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

HUS : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Jyvaskyla : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Kuopio : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Pori : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Turku : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Turku : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

France

Angers : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Angers cedex 9 : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Beuvry : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Beziers : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Briis Sous Forges : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Carbon Blanc : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Cournonterral : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dinard : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Donges : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Escoublac : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Grandchamps : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Grenoble : CHU de Grenoble

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

La Bouexiere : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

La Fôret sur Sèvres : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

La Montagne : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

La Teste de Buch : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Le Bono : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Lille : CHU de Lille

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Lyon cedex 04 : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Lyon cedex 04 : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Marseille : CHU Nord

Patients are needed to participate in a clinical research study of Simeox and Physiotherapy

Metz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Montpellier cedex 5 : GSK Investigational Site

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Muret : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Mûrs-Erigné : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Nantes : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Nantes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nantes : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Nice : CHU Hôpital Pasteur

Patients are needed to participate in a clinical research study of ELVR (Endoscopic Lung Volume Reduction) with Zephyr valve to evaluate COPD or Heterogeneous Emphysema

Nieul sur Mer : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Nimes Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Parcay les Pins : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Paris : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Perigny : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Pessac : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Reims : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Saint Etienne de Montluc : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Saint Georges de Montaigu : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Saint Max : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Sarrebourg : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Scorbe Clairvaux : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Seysses : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

St Genis des Fontaines : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Strasbourg : CHU de Strasbourg

Patients are needed to participate in a clinical research study of Holaira™ Lung Denervation System with energy delivery and Holaira™ Lung Denervation System without energy delivery to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Thouars : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Toulon : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Tours : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Tours : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Vannes : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Villey Saint Etienne : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Vitré : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Witry les Reims : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Germany

Aachen :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Aachen : Boehringer Ingelheim Investigational Site 358

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Alfeld : Boehringer Ingelheim Investigational Site 259

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Ansbach : Boehringer Ingelheim Investigational Site 2

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Asbach-Bäumenheim : Boehringer Ingelheim Investigational Site 76

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Aschaffenburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Aschaffenburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Auerbach : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Auerbach : Boehringer Ingelheim Investigational Site 169

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Auerbach : Boehringer Ingelheim Investigational Site 172

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Augsburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Augsburg : Boehringer Ingelheim Investigational Site 77

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Berka : Zentralklinik Bad Berka GmbH, Klinik für Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Bad Berleburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bad Friedrichshall : Boehringer Ingelheim Investigational Site 38

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Krozingen : Boehringer Ingelheim Investigational Site 62

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Langensalza : Boehringer Ingelheim Investigational Site 161

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Lippspringe : Boehringer Ingelheim Investigational Site 323

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Neustadt : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bad Reichenhall :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Bad Reichenhall : Boehringer Ingelheim Investigational Site 102

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Sachsa : Boehringer Ingelheim Investigational Site 262

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Windsheim : Boehringer Ingelheim Investigational Site 7

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bad Woerishofen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bad Woerishofen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bad Woerrishofen : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bad Wörishofen : Boehringer Ingelheim Investigational Site 74

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Baden-Baden : Boehringer Ingelheim Investigational Site 59

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bamberg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bamberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bamberg : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Beelitz-Heilstätten : Boehringer Ingelheim Investigational Site 217

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bensheim : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bensheim : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bensheim : Boehringer Ingelheim Investigational Site 144

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : HELIOS Klinikum Emil von Behring, Klinik für Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Berlin : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Berlin : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Berlin :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : 1237.16.49603 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QBM076 and placebo to evaluate COPD

Berlin : Boehringer Ingelheim Investigational Site 226

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 234

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 206

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 211

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 214

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 210

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 230

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 213

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 227

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 208

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 228

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 229

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 205

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Berlin : Boehringer Ingelheim Investigational Site 201

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bernkastel : Boehringer Ingelheim Investigational Site 103

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Biberach : Boehringer Ingelheim Investigational Site 71

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bielefeld : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bielefeld : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bielefeld : Boehringer Ingelheim Investigational Site 330

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bielefeld : Boehringer Ingelheim Investigational Site 331

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bochum : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bochum : 1237.16.49605 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Bochum : Boehringer Ingelheim Investigational Site 307

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bockenheim : Boehringer Ingelheim Investigational Site 130

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bodenwerder : Boehringer Ingelheim Investigational Site 260

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bonn : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bonn : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Bonn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bonn : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Bonn : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Bonn : Boehringer Ingelheim Investigational Site 361

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bonn : Boehringer Ingelheim Investigational Site 360

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bovenden : Evangelisches Krankenhaus Göttingen-Weende gGmbH, Abteilung für Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Braunschweig : Boehringer Ingelheim Investigational Site 266

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bremen : Boehringer Ingelheim Investigational Site 272

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bremen : Boehringer Ingelheim Investigational Site 276

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bremen : Boehringer Ingelheim Investigational Site 274

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bruchsal : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Bruchsal : Boehringer Ingelheim Investigational Site 47

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bruchweiler-Bärenbach : Boehringer Ingelheim Investigational Site 128

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Buchbach : Boehringer Ingelheim Investigational Site 100

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bünde : Boehringer Ingelheim Investigational Site 327

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Bünde : Boehringer Ingelheim Investigational Site 325

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Burgheim : Boehringer Ingelheim Investigational Site 78

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Calau : Boehringer Ingelheim Investigational Site 224

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Chemnitz : Boehringer Ingelheim Investigational Site 180

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Chemnitz : Boehringer Ingelheim Investigational Site 181

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Cloppenburg : Boehringer Ingelheim Investigational Site 282

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Cottbus : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Cottbus : Boehringer Ingelheim Investigational Site 232

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Cottbus : Boehringer Ingelheim Investigational Site 233

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Deggendorf : Boehringer Ingelheim Investigational Site 91

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Delitzsch : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Delitzsch : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dessau : Boehringer Ingelheim Investigational Site 245

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dessau - Roßlau : Boehringer Ingelheim Investigational Site 241

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dessau-Rosslau : Boehringer Ingelheim Investigational Site 240

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Donaustauf :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Dortmund : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Dortmund : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dortmund : Boehringer Ingelheim Investigational Site 311

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dortmund : Boehringer Ingelheim Investigational Site 309

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dortmund : Boehringer Ingelheim Investigational Site 310

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Drensteinfurt : Boehringer Ingelheim Investigational Site 318

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dresden : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Dresden : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Dresden :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Dresden : Boehringer Ingelheim Investigational Site 184

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dudenhofen : Boehringer Ingelheim Investigational Site 137

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Dueren : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Dueren : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Duisburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Duisburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Duisburg : Boehringer Ingelheim Investigational Site 291

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Duisburg : Boehringer Ingelheim Investigational Site 286

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Duisburg : Boehringer Ingelheim Investigational Site 293

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Duisburg : Boehringer Ingelheim Investigational Site 297

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Düsseldorf : Boehringer Ingelheim Investigational Site 348

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eggenfelden : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Eisenach : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Ellhofen : Boehringer Ingelheim Investigational Site 39

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Emmerich : Boehringer Ingelheim Investigational Site 290

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Erfurt : Boehringer Ingelheim Investigational Site 162

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Erlangen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Erlangen : Boehringer Ingelheim Investigational Site 6

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Erlensee : Boehringer Ingelheim Investigational Site 151

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eschborn : Boehringer Ingelheim Investigational Site 146

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Essen : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Essen : Boehringer Ingelheim Investigational Site 300

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Essen : Boehringer Ingelheim Investigational Site 299

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Essen : Boehringer Ingelheim Investigational Site 298

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Euskirchen : Boehringer Ingelheim Investigational Site 359

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eutin : Boehringer Ingelheim Investigational Site 195

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Eutin : Boehringer Ingelheim Investigational Site 194

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Falkensee : Boehringer Ingelheim Investigational Site 202

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Finsterwalde : Boehringer Ingelheim Investigational Site 231

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Floersheim : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Forchheim : Boehringer Ingelheim Investigational Site 9

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Framersheim : Boehringer Ingelheim Investigational Site 122

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Frankfurt : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Frankfurt : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Frankfurt : 1237.16.49606 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of QBM076 and placebo to evaluate COPD

Frankfurt : Boehringer Ingelheim Investigational Site 145

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt : Boehringer Ingelheim Investigational Site 148

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Frankfurt am Main : Boehringer Ingelheim Investigational Site 154

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freiberg : Boehringer Ingelheim Investigational Site 177

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freiburg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Freising : Boehringer Ingelheim Investigational Site 80

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freital : Boehringer Ingelheim Investigational Site 179

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freital : Boehringer Ingelheim Investigational Site 182

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Freudenberg : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Freudenberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Friedrichshafen : Boehringer Ingelheim Investigational Site 69

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Friedrichsthal : Boehringer Ingelheim Investigational Site 106

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Friedrichsthal : Boehringer Ingelheim Investigational Site 107

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Fürstenwalde : Boehringer Ingelheim Investigational Site 236

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Fürstenwalde : Boehringer Ingelheim Investigational Site 235

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gailsdorf : Boehringer Ingelheim Investigational Site 1

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gangkofen : Boehringer Ingelheim Investigational Site 93

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Garmisch-Partenkirchen : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Garmisch-Partenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Garmisch-Partenkirchen : Boehringer Ingelheim Investigational Site 88

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gauting :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Gauting : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Gauting : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Geesthacht : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Geesthacht : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Geesthacht : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Geesthacht : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Gelsenkirchen : Boehringer Ingelheim Investigational Site 302

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gelsenkirchen : Boehringer Ingelheim Investigational Site 301

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gelsenkirchen : Boehringer Ingelheim Investigational Site 303

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Geltow : Boehringer Ingelheim Investigational Site 223

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gera :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Germersheim : Boehringer Ingelheim Investigational Site 132

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Goch : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Goch : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Goch : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Göppingen : Boehringer Ingelheim Investigational Site 54

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Goslar : Boehringer Ingelheim Investigational Site 270

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Greifswald :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Groß Grönau : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Grosshansdorf : GSK Investigational Site

A Phase 2 clinical study for patients with Pulmonary Disease, Chronic Obstructive

Grosshansdorf : Pulmonary Research Institute at the Lung Clinic Grosshansdorf

Patients are needed to participate in a clinical research study of Aclidinium bromide and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Großhansdorf : Site 2020 - Pulmonary Research Institute at Hospital Grosshansdorf

Patients are needed to participate in a clinical research study of CHF 5259 and Placebo to evaluate Chronic Obstructive Pulmonary Disease

Großhansdorf : 1237.16.49604 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Großhansdorf :

Patients are needed to participate in a clinical research study of Roflumilast and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Gummersbach : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Gundelfingen : Boehringer Ingelheim Investigational Site 64

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Gütersloh : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Gütersloh : Boehringer Ingelheim Investigational Site 321

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hagen : HELIOS Klinik Hagen-Ambrock, Pneumologie / Endoskopie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Hagen : Helios Klinik Hagen

A clinical study for patients with COPD or Chronic Hypercapnic Respiratory Failure

Hagen : Helios Klinik Hagen

A clinical research study of Ergometer Training and Motivation for the treatment of COPD

Hagen : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Hagen : Helios Klinik Hagen

A clinical trial to evaluate treatments using BIPAP ST and Airtrap for patients with COPD or Hypercapnic Respiratory Failure

Hagen : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hagen : Helios Klinik Hagen Ambrock

Patients are needed to participate in a clinical research study evaluating High flow therapy for the treatment of Chronic Obstructive Pulmonary Disease

Hagen : Boehringer Ingelheim Investigational Site 336

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hagen : Boehringer Ingelheim Investigational Site 337

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hagen : Boehringer Ingelheim Investigational Site 333

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Halberstadt : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Halle :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Halle : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Halle : Boehringer Ingelheim Investigational Site 248

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Halle : Boehringer Ingelheim Investigational Site 247

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Halle : Boehringer Ingelheim Investigational Site 244

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Halle : Boehringer Ingelheim Investigational Site 239

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Halle / Saale : Boehringer Ingelheim Investigational Site 243

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Halle / Saale : Boehringer Ingelheim Investigational Site 242

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hamburg : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hamburg : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Hamburg : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Hamburg : GSK Investigational Site

A clinical trial to evaluate treatments using Mepolizumab and Placebo for patients with Pulmonary Disease, Chronic Obstructive

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hamburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hamburg : Research Site

Patients are needed to participate in a clinical research study evaluating Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Hamburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Hamburg : Chiesi Clinical Trial Site 2027

Patients are needed to participate in a clinical research study of CHF 5259 and Placebo to evaluate Chronic Obstructive Pulmonary Disease

Hamburg : Boehringer Ingelheim Investigational Site 190

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hamburg : Boehringer Ingelheim Investigational Site 191

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hamburg : Boehringer Ingelheim Investigational Site 188

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hamburg : Boehringer Ingelheim Investigational Site 189

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hamburg : Boehringer Ingelheim Investigational Site 192

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hamburg : Boehringer Ingelheim Investigational Site 193

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hameln : Boehringer Ingelheim Investigational Site 264

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hannover : GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Hannover : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Hannover : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Hannover : GSK Investigational Site

A clinical trial to evaluate treatments using FF, UMEC and VI for patients with Pulmonary Disease, Chronic Obstructive

Hannover : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Hannover : GSK Investigational Site

A clinical trial to evaluate treatments using FF/VI and VI for patients with Pulmonary Disease, Chronic Obstructive

Hannover : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Hannover :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Hannover :

Patients are needed to participate in a clinical research study of Roflumilast and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Hannover : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Hannover : GSK Investigational Site

Patients are needed to participate in a clinical research study of Umeclidinium and Glycopyrronium to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Hannover : Boehringer Ingelheim Investigational Site 255

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hannover : Boehringer Ingelheim Investigational Site 256

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hannover : Boehringer Ingelheim Investigational Site 254

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hannover : Boehringer Ingelheim Investigational Site 257

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hannover Münden : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Harburg :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Harsewinkel : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Heidelberg : Thoraxklinik Heidelberg

Patients are needed to participate in a clinical research study of IBV Implantation to evaluate Pulmonary Emphysema

Heidelberg : 1237.16.49601 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study of placebo to tiotropium + olodaterol, tiotropium and olodaterol to evaluate Pulmonary Disease, Chronic Obstructive

Heidelberg :

Patients are needed to participate in a clinical research study of Roflumilast and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Heidelberg : Heidelberg Hospital

Patients are needed to participate in a clinical research study of Zephyr Endobronchial Valve (EBV) to evaluate Pulmonary Emphysema

Heidelberg : Boehringer Ingelheim Investigational Site 40

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heidelberg : Boehringer Ingelheim Investigational Site 41

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heidelberg : Boehringer Ingelheim Investigational Site 37

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heilbronn : Boehringer Ingelheim Investigational Site 42

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heilbronn : Boehringer Ingelheim Investigational Site 18

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heilbronn : Boehringer Ingelheim Investigational Site 35

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heilbronn : Boehringer Ingelheim Investigational Site 43

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heilbronn : Boehringer Ingelheim Investigational Site 44

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Heinsberg-Karken : Boehringer Ingelheim Investigational Site 357

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Helmstedt : Boehringer Ingelheim Investigational Site 269

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hemer :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Hemmingen : Boehringer Ingelheim Investigational Site 253

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hemmingen : Boehringer Ingelheim Investigational Site 252

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hemsbach : Boehringer Ingelheim Investigational Site 27

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hemsbach : Boehringer Ingelheim Investigational Site 29

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Herford : Boehringer Ingelheim Investigational Site 329

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Herne : Boehringer Ingelheim Investigational Site 308

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Herne : Boehringer Ingelheim Investigational Site 305

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Herne : Boehringer Ingelheim Investigational Site 306

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hesse : Institut für klinische Forschung

Patients are needed to participate in a clinical research study evaluating BDP/FF/GB, Tiotropium and BDP/FF + Tiotropium for the treatment of Chronic Obstructive Pulmonary Disease

Hettstedt : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Hilden : Boehringer Ingelheim Investigational Site 350

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hildesheim : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Hildesheim : Boehringer Ingelheim Investigational Site 258

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hohenau : Boehringer Ingelheim Investigational Site 92

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Homburg : Klinik für Innere Medizin V, Universitätsklinikum Homburg, University of Homburg/Saar

Patients are needed to participate in a clinical research study evaluating Nasal oxygen insufflation with a TNI® 20 oxy device and Nasal insufflation of oxygen for the treatment of COPD or Hypercapnia

Homburg : Boehringer Ingelheim Investigational Site 127

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Homburg/Saar : Boehringer Ingelheim Investigational Site 129

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Hoyerswerda : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Hoyerswerda : Boehringer Ingelheim Investigational Site 185

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Ibbenbüren : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Ibbenbüren : Boehringer Ingelheim Investigational Site 315

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Immenhausen : Pneumologische Lehrklinik der Universitätsmedizin Göttingen

Patients are needed to participate in a clinical research study of Aclidinium bromide and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Ingelheim : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Issum : Boehringer Ingelheim Investigational Site 288

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Issum : Boehringer Ingelheim Investigational Site 289

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Jena : Boehringer Ingelheim Investigational Site 174

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Jena : Boehringer Ingelheim Investigational Site 176

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Karlsruhe : Boehringer Ingelheim Investigational Site 45

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kassel : Marienkrankenhaus Kassel gGmbH, Medizinische Klinik / Pneumologie

A clinical study for patients with COPD Chronic Obstructive Pulmonary Disease

Kassel : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Kassel : Novartis Investigative Site

A Phase 4 clinical study for patients with Chronic Obstructive Pulmonary Disease or COPD

Kassel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating UMEC/VI and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Kassel : Boehringer Ingelheim Investigational Site 157

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kempten :

A clinical research study of Lung Volume Reduction Coil (LVRC) System for the treatment of Emphysema or RePneu

Kevelaer : Boehringer Ingelheim Investigational Site 287

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kierspe : Boehringer Ingelheim Investigational Site 344

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kirchheilingen : Boehringer Ingelheim Investigational Site 160

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kirchheim/Teck : Boehringer Ingelheim Investigational Site 58

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kirchlengern : Boehringer Ingelheim Investigational Site 328

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kleinmachnow : Boehringer Ingelheim Investigational Site 362

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kleve : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Koblenz : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Koblenz : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Koblenz :

Patients are needed to participate in a clinical research study of CNTO 6785 and Placebo to evaluate Pulmonary Disease, Chronic Obstructive

Koblenz : Boehringer Ingelheim Investigational Site 117

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Koblenz : Boehringer Ingelheim Investigational Site 116

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Koeln : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Koeln : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Koethen : GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Pulmonary Disease, Chronic Obstructive

Köln : Novartis Investigative Site

A clinical trial to evaluate treatments for patients with COPD

Köln : Boehringer Ingelheim Investigational Site 353

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Köln : Boehringer Ingelheim Investigational Site 354

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Köthen : Boehringer Ingelheim Investigational Site 246

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Krefeld : Boehringer Ingelheim Investigational Site 346

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Krefeld : Boehringer Ingelheim Investigational Site 345

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Künzing : Boehringer Ingelheim Investigational Site 90

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Künzing : Boehringer Ingelheim Investigational Site 89

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Kyritz : Boehringer Ingelheim Investigational Site 203

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Lahnau : Boehringer Ingelheim Investigational Site 153

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Landsberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Landshut : Boehringer Ingelheim Investigational Site 95

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive

Landstuhl : Boehringer Ingelheim Investigational Site 126

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive